Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2011-5-24
pubmed:abstractText
Human immunodeficiency virus (HIV) infection is associated with insulin resistance. HIV type 1 Nef downregulates cell surface protein expression, alters signal transduction, and interacts with the cytoskeleton and proteins involved in actin polymerization. These functions are required for glucose uptake by insulin-stimulated adipocytes. We sought to determine whether Nef alters adipocyte glucose homeostasis. Using radiolabeled glucose, we found that adipocytes exposed to recombinant Nef took in 42% less glucose after insulin stimulation than did control cells. This reduction resulted from a Nef-dependent inhibition of glucose transporter 4 (GLUT4) trafficking, as assessed by means of immunofluorescence microscopy. Immunoblot analysis revealed a decrease in phosphorylation of signal transducing proteins after Nef treatment, and fluorescence microscopy showed a dramatic alteration in cortical actin organization. We conclude that Nef interferes with insulin-stimulated processes in adipocytes. We have identified HIV Nef, which is detectable and antigenic in serum samples from HIV-infected people, as a novel contributor to the development of insulin resistance.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1537-6613
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
203
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1824-31
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21606541-3T3-L1 Cells, pubmed-meshheading:21606541-Actins, pubmed-meshheading:21606541-Adipocytes, pubmed-meshheading:21606541-Animals, pubmed-meshheading:21606541-Blotting, Western, pubmed-meshheading:21606541-Cell Membrane, pubmed-meshheading:21606541-Dose-Response Relationship, Drug, pubmed-meshheading:21606541-Down-Regulation, pubmed-meshheading:21606541-GTPase-Activating Proteins, pubmed-meshheading:21606541-Glucose, pubmed-meshheading:21606541-Glucose Transporter Type 4, pubmed-meshheading:21606541-HIV Infections, pubmed-meshheading:21606541-HIV-1, pubmed-meshheading:21606541-Humans, pubmed-meshheading:21606541-Insulin, pubmed-meshheading:21606541-Insulin Resistance, pubmed-meshheading:21606541-Mice, pubmed-meshheading:21606541-Phosphorylation, pubmed-meshheading:21606541-Proto-Oncogene Proteins c-akt, pubmed-meshheading:21606541-Signal Transduction, pubmed-meshheading:21606541-nef Gene Products, Human Immunodeficiency Virus
pubmed:year
2011
pubmed:articleTitle
Nef inhibits glucose uptake in adipocytes and contributes to insulin resistance in human immunodeficiency virus type I infection.
pubmed:affiliation
Department of Pharmacological Sciences, State University of New York at Stony Brook, NY 11794-8153, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural